Dual effect of IL-4 on resistance to systemic gram-negative infection and production of TNF-α

Cytokine

Volumn 12, Issue 4, 2000, Pages 417-421

  Giampietri, A ^a   Grohmann, U ^a   Vacca, C ^a   Fioretti, M C ^a   Puccetti, P ^a   Campanile, F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

IL 12; IL 4; Septic shock; TNF

Indexed keywords

INTERLEUKIN 4; RECOMBINANT CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; INFECTION RESISTANCE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; SURVIVAL;

EID: 0033949017     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0576     Document Type: Article

References (15)

1. Banchereau J, Rybak ME. Interleukin-4. Thomson A. The Cytokine Handbook. 1995;99-126 Academic Press, San Diego.
2. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, Shires GT, Cerami A. Shock and tissue injury induced by recombinant human cachectin. Science. 234:1986;470-474.
3. Alexander HR, Doherty GM, Buresh CM, Venzon DJ, Norton JA. A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice. J Exp Med. 173:1991;1029-1032.
4. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA. Evidence for IFN-γ as a mediator of the lethality of endotoxin and tumor necrosis factor α J Immunol. 149:1992;1666-1670.
5. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P, Trinchieri G. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol. 25:1995;672-676.
6. Jain-Vora S, LeVine AM, Chroneos Z, Ross GF, Hull WM, Whitsett JA. Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa. Infect Immun. 66:1998;4229-4236.
7. Baumhofer JM, Beinhauer BG, Wang JE, Brandmeier H, Geissler K, Losert E, Philip R, Aversa G, Rogy MG. Gene transfer with IL-4 and IL-13 improves survival in lethal endotoxemia in the mouse and ameliorates peritoneal macrophages immune competence. Eur J Immunol. 28:1998;610-615.
8. Rogy MA, Auffenberg T, Espat NJ, Philip R, Remick D, Wollenberg GK, Copeland EM, Moldawer LL. Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med. 181:1995;2289-2293.
9. Campanile F, Binaglia L, Boraschi D, Tagliabue A, Fioretti MC, Puccetti P. Antibacterial resistance induced by recombinant interleukin 1 in myelosuppressed mice: effect of treatment schedule and correlation with colony-stimulating activity in the bloodstream. Cell Immunol. 128:1990;250-260.
10. Campanile F, Grohmann U, Giampietri A, Belladonna L, Fioretti MC, Puccetti P. Cytokine expression in experimental gram-negative infection. Fund Clin Immunol. 2:1994;97-99.
11. Campanile F, Giampietri A, Grohmann U, Belladonna ML, Fioretti MC, Puccetti P. Evidence for tumor necrosis factor α as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. Eur J Pharmacol. 307:1996;191-199.
12. Finkelman FD, Madden KB, Morris SC, Holmes JM, Boiani N, Katona IM, Maliszewski CR. Anti-cytokine antibodies as carrier proteins. J Immunol. 151:1993;1235-1244.
13. Heinzel FP, Rerko RM, Ling P, Hakimi J, Schoenhaut D. Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun. 62:1994;4244-4249.
14. Mattner F, Ozmen L, Podlaski FJ, Wilkinson VL, Presky DH, Gately MK, Alber G. Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock. Infect Immun. 65:1997;4734-4737.
15. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor α production. J Exp Med. 181:1995;537-546.